3 Companies Redefining Healthcare Innovation
This article was originally published on ETFTrends.com. The Healthcare Technology and Innovation index (HTEC) was launched back in…
Definium LSD therapy for major depression helped patients in Phase 3 trial
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus
Eledon Pharmaceuticals, Inc. Tegoprubart-treated patients maintained higher mean eGFR over time, including a statistically significant approximately 12 mL/min/1.73…
Fish oil supplements may not prevent Alzheimer’s-related decline
LOS ANGELES — Americans spend more than $1 billion annually on fish oil supplements, in part due to purported cognitive…
The Drug That Bought My Father More Time Didn’t Happen by Accident
I still remember the day my father and I sat in his oncologist’s office and first heard the…
TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 Trial
TG Therapeutics, Inc. 82% of subjects achieved an MCID in their MG-ADL with a mean >4 point improvement…
AI-designed ‘universal vaccine’ candidate passes first human trial
Image: © Bill Oxford | iStock An innovative universal vaccine technology has successfully completed its first human clinical…
Lab Research Suggests Magnetic Particle Imaging May Help Researchers Find More Effective Ways to Deliver Cell Therapies
Newswise — Scientists at Johns Hopkins Medicine say they used a form of magnetic imaging to track cell…
Breakthrough in cancer immunotherapy: Promising therapy for advanced solid tumours
Image: © koto_feja | iStock As part of a clinical study, the Early Clinical Trial Unit (ECTU) at…
The Supplement That Science Says Could Make the World Less Angry
If you found out a supplement existed that could lower aggression, you would probably think it was something…
Industry and regulators signal a smarter, collaborative era for supplement oversight
While the industry has spent years bracing for and fending off a heavier regulatory hand, what it heard…
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting
TG Therapeutics, Inc. NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced…